Related Experiment Video
Updated: Apr 15, 2026

Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine
Published on: November 4, 2018
Liver-targeted gene therapy: Approaches and challenges
Rajagopal N Aravalli1, John D Belcher2, Clifford J Steer2,3
1Departments of Radiology, Cell Biology, and Development, University of Minnesota Medical School, Minneapolis, MN.
Abstract:
The liver plays a major role in many inherited and acquired genetic disorders. It is also the site for the treatment of certain inborn errors of metabolism that do not directly cause injury to the liver. The advancement of nucleic acid-based therapies for liver maladies has been severely limited because of the myriad untoward side effects and methodological limitations. To address these issues, research efforts in recent years have been intensified toward the development of targeted gene approaches using novel genetic tools, such as zinc-finger nucleases, transcription activator-like effector nucleases, and clustered regularly interspaced short palindromic repeats as well as various nonviral vectors such as Sleeping Beauty transposons, PiggyBac transposons, and PhiC31 integrase. Although each of these methods uses a distinct mechanism of gene modification, all of them are dependent on the efficient delivery of DNA and RNA molecules into the cell. This review provides an overview of current and emerging therapeutic strategies for liver-targeted gene therapy and gene repair.
Insights
Novel gene therapy tools show promise for liver genetic disorders. Researchers are developing targeted gene approaches using advanced technologies to overcome limitations in treating liver diseases effectively.
Area of Science:
- Hepatology
- Molecular Biology
- Genetic Medicine
Background:
- The liver is central to many inherited and acquired genetic disorders and metabolic diseases.
- Current nucleic acid-based therapies for liver conditions face significant side effects and limitations.
Purpose of the Study:
- To review current and emerging therapeutic strategies for liver-targeted gene therapy and gene repair.
- To highlight advancements in genetic tools and delivery vectors for liver gene modification.
Main Methods:
- Review of novel genetic tools including zinc-finger nucleases, transcription activator-like effector nucleases, and CRISPR-Cas9.
- Examination of nonviral vectors like Sleeping Beauty transposons, PiggyBac transposons, and PhiC31 integrase.
- Focus on efficient DNA and RNA delivery methods into liver cells.
Main Results:
- Identification of advanced genetic tools for precise gene modification in the liver.
- Evaluation of various nonviral vectors for effective gene delivery.
- Emphasis on the critical role of efficient molecular delivery for therapeutic success.
Conclusions:
- Targeted gene approaches using novel genetic tools and vectors offer promising therapeutic strategies for liver diseases.
- Overcoming delivery limitations is key to advancing liver-targeted gene therapy and gene repair.
- Continued research in this area holds potential for treating a range of liver genetic disorders.
Related Concept Videos
Gene Therapy
Gene Therapy
Microorganisms in Medicine and Therapeutics
Targeted Cancer Therapies
There are several types of targeted therapies against...
Pharmacogenomics: Identification of New Drug Targets

